Skip to main content
SpringerLink
Log in

Advances in esophageal stenting: the evolution of fully covered stents for malignant and benign disease

  • Review
  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Self-expanding metal stents have become a leading palliative therapy for dysphagia resulting from esophageal, proximal gastric, and mediastinal cancers. Increasingly, fully covered self-expanding plastic stents and now fully covered metal stents have been used to treat a variety of benign esophageal conditions as well as cancer. Several stent designs are available in the United States and many more internationally. Each design has advantages and limitations. Knowledge of the indications for esophageal stenting and the common side effects associated with different designs allows physicians to choose the best stent for a given condition as well as to anticipate complications such as stent migration or restenosis. Compared with partially covered stents, newer, fully covered metal stents may promote less granulation tissue and subsequent stenosis and may be removable even after several weeks. However, the tradeoff may be more frequent migration. Interest in fully covered metal stents in place of fully covered plastic stents for use in strictures and leaks has also grown, despite the lack of a formal indication for metal stents in benign disease. Unfortunately, rigorous studies of newer stent designs are currently lacking.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. O’Donnell CA, Fullarton GM, Watt E, et al. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg. 2002;89:985–992.

    Article  PubMed  Google Scholar 

  2. American Cancer Society. Cancer Facts and Figures 2006. Atlanta, GA: American Cancer Society; 2006.

    Google Scholar 

  3. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23–47.

    Article  PubMed  Google Scholar 

  4. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  5. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305–313.

    CAS  PubMed  Google Scholar 

  6. Coia LR, Engstrom PF, Paul AR, et al. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys. 1991;20:29–36.

    CAS  PubMed  Google Scholar 

  7. Homs M, Steyeberg EW, Eijkenboom W, et al. Single dose brachytherapy versus metal stent placement for the palliation of obstructive oesophageal cancer: a randomized trial. Lancet. 2004;364:1497–1504.

    Article  PubMed  Google Scholar 

  8. Kinsman KJ, DeGregorio BT, Katon RM, et al. Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy. Gastrointest Endosc. 1996;43:196–203.

    Article  CAS  PubMed  Google Scholar 

  9. Homs MY, Hansen BE, van Blankenstein M, et al. Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma. Eur J Gastroenterol Hepatol. 2004;16:163–170.

    Article  PubMed  Google Scholar 

  10. Canto MI, Smith C, McClelland L, et al. Randomized trial of PDT vs. stent for palliation of malignant dysphagia: cost-effectiveness and quality of life. Gastrointest Endsoc. 2002;55:AB100.

    Google Scholar 

  11. Dallal HJ, Smith GD, Grieve DC, et al. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc. 2001;54:549–557.

    Article  CAS  PubMed  Google Scholar 

  12. Sharma P, Kozarek R. Role of esophageal stents in benign and malignant disease. Am J Gastroenterol. 2010;105:258–273.

    Article  PubMed  Google Scholar 

  13. Bethge N, Somer A, Grosss U, et al. Human tissue responses to metal stents implanted in vivo for the palliation of malignant stenoses. Gastrointest Endosc. 1996;43:596–602.

    Article  CAS  PubMed  Google Scholar 

  14. Verschuur EML, Repici A, Kuipers EJ, et al. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol. 2008;103:304–312.

    Article  PubMed  Google Scholar 

  15. Dua KS, Vleggaar FP, Santharam R, et al. Removable self-expanding plastic esophageal stent as a continuous, non-permanent dilator in treating refractory benign esophageal stricture: a prospective two center study. Am J Gastroenterol. 2008;103:2988–2994.

    Article  PubMed  Google Scholar 

  16. Holm AN, de la Mora Levy JG, Gostout CJ, et al. Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc. 2007;67:20–25.

    Article  PubMed  Google Scholar 

  17. Ott C, Ratiu N, Endlicher E, et al. Self-expanding Polyflex plastic stents in esophageal disease: various indications, complications, and outcomes. Surg Endosc. 2006;21:889–896.

    Article  Google Scholar 

  18. Uidehaag MJ, van Hooft JE, Verschuur EML, et al. A fully-covered stent (Alimaxx-E) for the palliation of malignant dysphagia: a prospective follow-up study. Gastrointest Endosc. 2009;70:1082–1089.

    Article  Google Scholar 

  19. Price L, Koehler R, Schembre D, et al. The first North American experience with a removable esophageal stent for benign and malignant indications. Presented at: American College of Gastroenterology Annual Meeting, San Diego, CA, USA, October 23–28, 2009.

  20. Uitdehaag MJ, Siersema PD, Spaander MCW, et al. A new fully covered stent with antimigration properties for the palliation of malignant dysphagia: a prospective cohort study. Gastrointest Endosc. 2010;71:600–605.

    Article  PubMed  Google Scholar 

  21. Knyrim K, Wagner HJ, Bethage N, et al. A controlled trial of an expandable metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med. 1993;329:1302–1307.

    Article  CAS  PubMed  Google Scholar 

  22. Vakil N, Morris AI, Marcon N, et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol. 2001;96:1791–1796.

    Article  CAS  PubMed  Google Scholar 

  23. Sabharwal T, Hamady MS, Chui S, et al. A randomized prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut. 2003;52:922–926.

    Article  CAS  PubMed  Google Scholar 

  24. Siersema PD, Hop WC, van Blankenstein M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc. 2001;54:145–153.

    CAS  PubMed  Google Scholar 

  25. Conio M, Recipi A, Battaglia G, et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol. 2007;102:2667–2677.

    Article  PubMed  Google Scholar 

  26. Kozarek RA, Ball TJ, Patterson DJ: Metallic self-expanding stent applications in the upper gastrointestinal tract: caveats and concerns. Gastrointest Endosc. 1992;38:1–6.

    Article  CAS  PubMed  Google Scholar 

  27. Dirks K, Schulz T, Schellmann B, et al. Fatal hemorrhage following perforation of the aorta by a barb of the Gianturco-Rosch esophageal stent. Zeitschrift fur Gastroenterol. 2002;40:81–84.

    Article  CAS  Google Scholar 

  28. Mersol J, Kozarek R. Spine complications of stent placement. Gastrointest Endosc. 2002;55:241.

    Article  PubMed  Google Scholar 

  29. Binkert C, Petersen B. Two fatal complications after parallel tracheal-esophageal stenting. Cardiovasc Interventional Rad. 2002;25:144–147.

    Article  Google Scholar 

  30. Baron TH. A practical guide for choosing an expandable metal stent for GI malignancies: is a stent by any other name still a stent? Gastrointest Endosc. 2001;54:269–271.

    CAS  PubMed  Google Scholar 

  31. Homann N, Noftz MR, Klingenberg-Noftz RD, et al. Delayed complications after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate. Dig Dis Sci. 2008;53:334–340.

    Article  PubMed  Google Scholar 

  32. Baron TH. Minimizing endoscopic complications: endoluminal stents. Gastrointest Endosc Clin N Am. 2007;17:83–104.

    Article  PubMed  Google Scholar 

  33. Papachristou GI, Baron TH. Use of stents in benign and malignant esophageal disease. Rev Gastroenterol Disord. 2007;7:74–88.

    PubMed  Google Scholar 

  34. Ross WA, Alkassab F, Lynch PM, et al. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc. 2007;65:70–76.

    Article  PubMed  Google Scholar 

  35. Radecke K, Gerken G, Treicel U. Impact of a self-expanding, plastic esophageal stent on various esophageal stenoses, fistulas, and leakages: a single-center experience in 39 patients. Gastrointest Endosc. 2005;61:812–818.

    Article  PubMed  Google Scholar 

  36. Edvard S, Le Moine O, Lazaraki G, et al. Self-expanding plastic stents for benign esophageal lesions. Gastrointest Endosc. 2004;60;894–900.

    Article  Google Scholar 

  37. Repici A, Conio M, DeAngelis C, et al. Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures. Gastrointest Endosc. 2004;60:513–519.

    Article  PubMed  Google Scholar 

  38. Karbowski M, Schembre D, Kozarek R, et al. Polyflex self-expanding, removable plastic stents: assessment of treatment efficacy and safety in a variety of benign and malignant conditions of the esophagus. Surg Endosc. 2008;22:1326–1333.

    Article  CAS  PubMed  Google Scholar 

  39. Siersema PD. Endoscopic therapeutic esophageal interventions: what is new? What needs further study? What can we forget? Curr Opin Gastroenterol. 2005;21:490–497.

    PubMed  Google Scholar 

  40. Eloubeidi, MA, Lopes TL. Novel removable internally fully covered self-expanding metal esophageal stent: feasibility, technique of removal, and tissue response in humans. Am J Gastroenterol. 2009;104:1374–1381.

    Article  PubMed  Google Scholar 

  41. Lee BI, Choi KY, Kang HJ, et al. Sealing an extensive anastomotic leak after esophagojejunostomy with an antimigration-modified covered self-expanding metal stent. Gastrointest Endosc. 2006;64:1024–1025.

    Article  PubMed  Google Scholar 

  42. Freeman RK, Van Woerkom JM, Ascioti AJ. Esophageal stent placement for the treatment of iatrogenic intrathoracic esophageal perforation. Ann Thoracic Surg. 2007;83:2003–2008.

    Article  Google Scholar 

  43. Tuebergen D, Rijcken E, Mennigen R, et al. Treatment of thoracic esophageal anastomotic leaks and esophageal perforations with endoluminal stents: efficacy and current limitations. J Gastrointest Surg. 2008;12:1168–1176.

    Article  PubMed  Google Scholar 

  44. Siddiqui AA, Glynn C, Loren D, et al. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study. Dis Esophagus. 2009;22:216–222.

    Article  CAS  PubMed  Google Scholar 

  45. Adler DG, Fang J, Wong R, Wills J, Hilden K. Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapy. Gastrointest Endosc. 2009;70:614–619.

    Article  PubMed  Google Scholar 

  46. Hubmann R, Bodlaj G, Czompo M, et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy. 2006;38:896–901.

    Article  CAS  PubMed  Google Scholar 

  47. Saito Y, Tanaka T, Andoh A, et al. Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci. 2008;53:330–333.

    Article  CAS  PubMed  Google Scholar 

  48. De Palma GD, Lovino P, Masone S, et al. Self-expanding metal stents for endoscopic treatment of esophageal achalasia unresponsive to conventional treatments. Long-term results in eight patients. Endoscopy. 2001;33:1027–1030.

    Article  PubMed  Google Scholar 

  49. Repici A, Vleggaar F, Calino A, et al. Benign refractory esophageal strictures: preliminary results from the BEST (Biodegradable Esophageal STent) study. Gastrointest Endosc. 2009;69:123.

    Google Scholar 

  50. Jeon SR, Shim CS, Ryu CB, et al. Effect of drug-eluting metal stents in benign esophageal stricture: an in vivo animal study. Endosc. 2009;41:449–456.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Virginia Mason Medical Centre, 1100 9th Ave., Seattle, WA, 98101, USA

    Drew Schembre

Authors
  1. Drew Schembre
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Drew Schembre.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schembre, D. Advances in esophageal stenting: the evolution of fully covered stents for malignant and benign disease. Adv Therapy 27, 413–425 (2010). https://doi.org/10.1007/s12325-010-0042-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-010-0042-5

Keywords

Search

Navigation